Agarwal Arjun 4

What Happened
Arjun Agarwal, Senior Vice President, Finance at Oruka Therapeutics (ORKA), disposed of 395 shares on 2026-03-16 in an open-market/private sale at $41.30 per share, for a total of $16,313. The sale was effected as part of an automatic sell-to-cover to satisfy tax withholding obligations tied to vested restricted stock units.

Key Details

• Transaction date and price: 2026-03-16 — 395 shares sold at $41.30/share (total $16,313).
• Reason/footnote: Sale effected pursuant to Oruka’s automatic, non-discretionary sell-to-cover procedure to satisfy tax withholding on RSU vesting (Footnote F1).
• Shares owned after transaction: Not disclosed in the Form 4 filing.
• Filing: Report filed 2026-03-17 for the 2026-03-16 transaction — within typical SEC Form 4 timing requirements (timely).

Context
Sell-to-cover transactions are common when restricted stock units vest and do not necessarily indicate an insider’s view on the company’s prospects; they are routine tax-withholding actions rather than discretionary sales. For investors, purchases generally carry more weight as a positive signal than routine sales like this one.